Tris Phar­ma de­clares Phase 3 win for 'o­pi­oid-like' painkiller. Can it sell?

A biotech de­vel­op­ing what it says is an “opi­oid-like” pain re­liev­er re­leased Phase 3 da­ta Wednes­day morn­ing claim­ing the drug can re­duce post-op­er­a­tive pain for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER